Dennis Ledford
Allergy & Immunology · Tampa, FLNPI 1376528042
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $944,746 of the $1,186,289 with a category attached, or 79.6%. 29 manufacturers reported payments, led by AstraZeneca at 30.7% of the total. Among allergy & immunology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,201 payments — averaging $987.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$364K
- GSK$338K
- Sanofi$191K
- Regeneron Healthcare Solutions, Inc.$126K
- Genentech USA, Inc.$72K
- Novartis$22K
- plus $73K from 23 others
Across 79 payments — averaging $2488.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$87K
- Takeda Pharmaceuticals U.S.A., Inc.$43K
- Roche Products Limited$38K
- AstraZeneca$26K
- Acerta Pharma LLC$3K
What the payments were for
- Consulting fees$90,8338%
- Speaking & faculty fees$944,74680%
- Travel & lodging$120,35010%
- Food & beverage$30,2153%
- Education$1440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 376 | $364,434 |
| GSK | 299 | $337,891 |
| Sanofi | 143 | $190,837 |
| Regeneron Healthcare Solutions, Inc. | 134 | $125,822 |
| Genentech USA, Inc. | 74 | $71,614 |
| Novartis | 39 | $22,209 |
| Amgen | 19 | $21,799 |
| Alk-abello, Inc | 19 | $16,553 |
| CSL Behring | 27 | $13,141 |
| Biocryst Pharmaceuticals, Inc. | 9 | $8,484 |
| Teva Pharmaceuticals USA, Inc. | 3 | $4,572 |
| Boehringer Ingelheim | 9 | $3,863 |
| Blueprint Medicines Corporation | 3 | $2,092 |
| AbbVie | 2 | $1,757 |
| Shire North American Group Inc | 18 | $209 |
| Biocryst US Sales Co., LLC | 2 | $200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $191 |
| ADMA Biomanufacturing LLC | 1 | $129 |
| Circassia Inc. | 1 | $97 |
| Lilly USA, LLC | 4 | $90 |
| Covis Pharma GmbH | 3 | $61 |
| Sanofi-aventis U.S. LLC | 2 | $60 |
| Optinose US, Inc. | 3 | $48 |
| Pfizer | 3 | $40 |
| Octapharma USA, Inc. | 1 | $32 |
| Grifols USA, LLC | 1 | $19 |
| Insmed, Inc. | 1 | $17 |
| Pharming Healthcare, Inc. | 1 | $15 |
| Kaleo, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUCALA$314,876
- DUPIXENT$259,304
- FASENRA$136,040
- AIRSUPRA$111,831
- TEZSPIRE$109,223
- XOLAIR$57,419
- Odactra$16,473
- Andembry$8,110
- Rhapsido$5,473
- AirDuo RespiClick$4,560
- ProAir Digihaler$4,560
- ArmonAir Digihaler$4,560
- TRELEGY ELLIPTA$2,400
- Esbriet$2,220
- Ragwitek$145
- Grastek$145
- QGE031$116
- Orladeyo$115
How this compares
$1,186,289 in reported general payments places this provider in the 95th percentile of 204 allergy & immunology providers in Florida.
Other allergy & immunology in Tampa
- Thomas CasaleTampa$382K
- Mark GlaumTampa$337K
- Juan Carlos CardetTampa$180K
- Farnaz TabatabaianTampa$76K
- Seong ChoTampa$42K
- Richard LockeyTampa$27K
- Ammar HatabTampa$14K
- Richard SiegelTampa$13K
- Nina RamirezMiami$833K
- Thomas WestbrookPensacola$810K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.